1
TITLE: Improving non-small-cell lung cancer survival through molecular characterization: Perspective of a multidisciplinary expert panel
AUTHORS: Fernandes, M. G. O. ; Vilarica, A. S.; Fernandes, B.; Camacho, C.; Saraiva, C.; Estevinho, F.; Novais e Bastosa, H. ; Lopes, J. M.; Fidalgo, P.; Garrido, P.; Alves, S.; Silva, S.; Sequeira, T.; Barata, F.;
PUBLISHED: 2024, SOURCE: PULMONOLOGY, VOLUME: 30, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef
2
TITLE: Liquid biopsy: The value of different bodily fluids
AUTHORS: Vanessa Santos; Claudia Freitas; Maria G O Fernandes ; Catarina Sousa; Cristina Reboredo; Natalia Cruz Martins ; Joaquin Mosquera; Venceslau Hespanhol ; Rosario Campelo;
PUBLISHED: 2022, SOURCE: Biomarkers in Medicine, VOLUME: 16, ISSUE: 2
INDEXED IN: Scopus CrossRef: 1
3
TITLE: NANOTECHNOLOGY-BASED DELIVERY SYSTEMS FOR TYROSINE KINASES INHIBITORS IN NON-SMALL CELL LUNG CANCER TREATMENT
AUTHORS: Sousa, C; Jacob, M; Beshbishy, AM; Batiha, GE; Cruz Martins, N; Fernandes, MGO ;
PUBLISHED: 2022, SOURCE: Biogenic Nanomaterials: Structural Properties and Functional Applications
INDEXED IN: Scopus
5
TITLE: Resistance to anti-EGFR therapy is transferred horizontally between lung cancer cells through caveolin-associated intercellular trafficking
AUTHORS: Junqueira Neto, Susana; Oliveira, Ana Rita; Marques, Joana Fernandes; Fernandes, Gabriela ; Hespanhol, Venceslau ; Moura, Conceicao Souto; Melo, Sonia Almeida; Costa, Jose Luis; Machado, Jose Carlos ;
PUBLISHED: 2022, SOURCE: Annual Meeting of the American-Association-for-Cancer-Research (AACR) in CANCER RESEARCH, VOLUME: 82, ISSUE: 12
INDEXED IN: WOS
9
TITLE: Management of Coronavirus Disease 2019 Patients With Lung Cancer: Experience From a Thoracic Oncology Center
AUTHORS: Coelho, David Barros; Santos, Vanessa; Araujo, David; Bastos, Helder Novais ; Magalhaes, Adriana; Hespanhol, Venceslau ; Queiroga, Henrique; Cruz Martins, Natalia ; Fernandes, Maria Gabriela O. ;
PUBLISHED: 2021, SOURCE: FRONTIERS IN MOLECULAR BIOSCIENCES, VOLUME: 8
INDEXED IN: WOS CrossRef
10
TITLE: Modified Glasgow Prognostic Score predicts survival among advanced non-small cell lung carcinoma patients treated with anti-PD1 agents
AUTHORS: Freitas, C ; Jacob, M; Tavares, N; Cruz Martins, N; Souto Moura, C; Araujo, D; Novais Bastos, H ; Santos, V; Fernandes, G ; Magalhaes, A; Hespanhol, V; Queiroga, H;
PUBLISHED: 2021, SOURCE: ANTI-CANCER DRUGS, VOLUME: 32, ISSUE: 5
INDEXED IN: Scopus WOS CrossRef: 3
IN MY: ORCID
Page 1 of 2. Total results: 12.